BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28611670)

  • 1. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
    Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
    Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
    Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
    Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
    Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
    Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
    Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
    IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
    Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
    Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
    Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
    Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
    Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
    Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.
    Li N; Liu X
    Onco Targets Ther; 2020; 13():1787-1795. PubMed ID: 32161473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate.
    Oslund RC; Su X; Haugbro M; Kee JM; Esposito M; David Y; Wang B; Ge E; Perlman DH; Kang Y; Muir TW; Rabinowitz JD
    Nat Chem Biol; 2017 Oct; 13(10):1081-1087. PubMed ID: 28805803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting PGAM1 in cancer: An emerging therapeutic opportunity.
    Yang GJ; Tao F; Zhong HJ; Yang C; Chen J
    Eur J Med Chem; 2022 Dec; 244():114798. PubMed ID: 36215859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
    Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
    Nat Commun; 2013; 4():1790. PubMed ID: 23653202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
    Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
    J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors.
    Huang K; Jiang L; Li H; Ye D; Zhou L
    Molecules; 2019 Feb; 24(5):. PubMed ID: 30818883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.
    Huang K; Liang Q; Zhou Y; Jiang LL; Gu WM; Luo MY; Tang YB; Wang Y; Lu W; Huang M; Zhang SZ; Zhuang GL; Dai Q; Shen QC; Zhang J; Lei HM; Zhu L; Ye DY; Chen HZ; Zhou L; Shen Y
    Cell Metab; 2019 Dec; 30(6):1107-1119.e8. PubMed ID: 31607564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides.
    Evans MJ; Morris GM; Wu J; Olson AJ; Sorensen EJ; Cravatt BF
    Mol Biosyst; 2007 Jul; 3(7):495-506. PubMed ID: 17579775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.
    Hallows WC; Yu W; Denu JM
    J Biol Chem; 2012 Feb; 287(6):3850-8. PubMed ID: 22157007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.
    Wen CL; Huang K; Jiang LL; Lu XX; Dai YT; Shi MM; Tang XM; Wang QB; Zhang XD; Wang PH; Li HT; Ruan XX; Wang LW; Wang XJ; Wang Q; Lu W; Xiang XQ; Sun X; Xu YH; Lai LH; Zhan Q; Li HW; Peng CH; Chen J; Huang JY; Ye DY; Chen SJ; Chen Z; Li M; Fang Y; Shen BY; Zhou L
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23264-23273. PubMed ID: 31662475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGAM1 Promotes Glycolytic Metabolism and Paclitaxel Resistance via Pyruvic Acid Production in Ovarian Cancer Cells.
    Feng Y; Zhang X; Zhang S; Xu S; Chen X; Zhou C; Xi Y; Xie X; Lu W
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):262. PubMed ID: 36224008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
    Jiang X; Sun Q; Li H; Li K; Ren X
    Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
    Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.